<p>Clinical changes over treatment period of 16 weeks are shown. Four of the five patients showed improvements in 2 min walking distance (A), the MFM total score (B) and the MFM D1 subscore (C).</p
<p>With the use of Wilcoxon Rank Test according to baseline walking distance, p<0.001 was obtained f...
INTRODUCTION: Duchenne muscular dystrophy (DMD) subjects ≥5 years with nonsense mutations were follo...
SummaryThe aim of this study was to determine the minimal important difference for the six-minute wa...
<p>Improvement of clinical pathology and of life quality four weeks after treatment (n = 46).</p
Most of the patients experienced an improving trend in clinical symptoms within 9 months after the f...
<p>Changes in 6MWD were studied over approximate 1-year follow-up intervals (8–16 months). If a pati...
The 6 minute walk test has been recently chosen as the primary outcome measure in international mult...
The 6 minute walk test has been recently chosen as the primary outcome measure in international mult...
The 6 minute walk test has been recently chosen as the primary outcome measure in international mult...
<div><p>The 6 minute walk test has been recently chosen as the primary outcome measure in internatio...
Deficits in ambulatory function progress at heterogeneous rates among individuals with Duchenne musc...
ObjectivesThe purpose of this study was to investigate the prognostic value of change in distance wa...
<p>Patients with relapsing-remitting multiple sclerosis were categorized as improved, stable, or wor...
<p>Open circles, ghrelin; closed circles, placebo. Data are presented as mean differences±SE. * p<0....
IntroductionDuchenne muscular dystrophy (DMD) subjects ≥5 years with nonsense mutations were followe...
<p>With the use of Wilcoxon Rank Test according to baseline walking distance, p<0.001 was obtained f...
INTRODUCTION: Duchenne muscular dystrophy (DMD) subjects ≥5 years with nonsense mutations were follo...
SummaryThe aim of this study was to determine the minimal important difference for the six-minute wa...
<p>Improvement of clinical pathology and of life quality four weeks after treatment (n = 46).</p
Most of the patients experienced an improving trend in clinical symptoms within 9 months after the f...
<p>Changes in 6MWD were studied over approximate 1-year follow-up intervals (8–16 months). If a pati...
The 6 minute walk test has been recently chosen as the primary outcome measure in international mult...
The 6 minute walk test has been recently chosen as the primary outcome measure in international mult...
The 6 minute walk test has been recently chosen as the primary outcome measure in international mult...
<div><p>The 6 minute walk test has been recently chosen as the primary outcome measure in internatio...
Deficits in ambulatory function progress at heterogeneous rates among individuals with Duchenne musc...
ObjectivesThe purpose of this study was to investigate the prognostic value of change in distance wa...
<p>Patients with relapsing-remitting multiple sclerosis were categorized as improved, stable, or wor...
<p>Open circles, ghrelin; closed circles, placebo. Data are presented as mean differences±SE. * p<0....
IntroductionDuchenne muscular dystrophy (DMD) subjects ≥5 years with nonsense mutations were followe...
<p>With the use of Wilcoxon Rank Test according to baseline walking distance, p<0.001 was obtained f...
INTRODUCTION: Duchenne muscular dystrophy (DMD) subjects ≥5 years with nonsense mutations were follo...
SummaryThe aim of this study was to determine the minimal important difference for the six-minute wa...